References
- VoelkelNFQuaifeRALeinwandLARight ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failureCirculation2006114171883189117060398
- LiWSamaAEWangHCRole of HMGB1 in cardiovascular diseasesCurr Opin Pharmacol20066213013516487750
- Sadamura-TakenakaYItoTNomaSHMGB1 promotes the development of pulmonary arterial hypertension in ratsPLoS One201497e10248225032709
- BauerEMShapiroRZhengHHigh mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4Mol Med2012181509151823269975
- PriceLCWortSJPerrosFInflammation in pulmonary arterial hypertensionChest2012141121022122215829
- TuderRMArcherSLDorfmüllerPRelevant issues in the pathology and pathobiology of pulmonary hypertensionJ Am Coll Cardiol20136225 SupplD4D1224355640
- GrothAVrugtBBrockMSpeichRUlrichSHuberLCInflammatory cytokines in pulmonary hypertensionRespir Res2014151475724739042
- HassounPMInflammation in pulmonary arterial hypertension: is it time to quell the fire?Eur Respir J201443368568824585865
- BrockMTrenkmannMGayREInterleukin-6 modulates the expression of the bone morphogenic protein receptor type ii through a novel stat3-microRNA cluster 17/92 pathwayCirc Res2009104101184119119390056
- FirthALYuillKHSmirnovSVMitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cellsAm J Physiol Lung Cell Mol Physiol20082951L61L7018469114
- HuHLZhangZXChenCSCaiCZhaoJPWangXDEffects of mitochondrial potassium channel and membrane potential on hypoxic human pulmonary artery smooth muscle cellsAm J Respir Cell Mol Biol201042666166619617400
- YangPSKimDHLeeYJGlycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in ratsRespir Res201415114825420924
- KaoKKFinkMPThe biochemical basis for the anti-inflammatory cytoprotective actions of ethyl pyruvate and related compoundsBiochem Pharmacol201080215115920230800
- FinkMPEthyl pyruvate: a novel anti-inflammatory agentJ Intern Med2007261434936217391109
- MatoneJMorettiAIApodaca-TorrezFRGoldenbergAEthyl-pyruvate reduces lung injury matrix metalloproteinases and cytokines and improves survival in experimental model of severe acute pancreatitisActa Cir Bras201328855956723896834
- LiuCFangCCaoGEthyl pyruvate ameliorates monocrotaline-induced pulmonary arterial hypertension in ratsJ Cardiovasc Pharmacol20146171524492475
- KawashimaYYamamotoHTakeuchiHHinoTNiwaTProperties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methodsEur J Pharm Biopharm199845141489689534
- KawashimaYYamamotoHTakeuchiHFujiokaSHinoTPulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (LG) nanospheres to prolong hypoglycemic effectJ Control Release1999621–227928710518661
- LiuKLiuRCaoGSunHWangXWuSAdipose-derived stromal cell autologous transplantation ameliorates pulmonary arterial hypertension induced by shunt flow in rat modelsStem Cells Dev20112061001101020828291
- EverettADLe CrasTDXueCJohnsRAeNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flowAm J Physiol19982746 Pt 1L1058L10659609746
- MegalouAJGlavaCOikonomidisDLTransforming growth factor-β inhibition attenuates pulmonary arterial hypertension in ratsInt J Clin Exp Med20103433234021072267
- MillerFJJrGuttermanDDRiosCDHeistadDDDavidsonBLSuperoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosisCirc Res19988212129813059648726
- WangXPChenYGQinWDArginase I attenuate inflammatory cytokine secretion induced by lipopolysaccharide in vascular smooth muscle cellsArterioscler Thromb Vasc Biol20113181853186021617140
- BejmaJRamiresPJiLLFree radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liverActa Physiol Scand2000169434335110951126
- LebelCPBondySCSensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomesNeurochem Int199017343544020504643
- LiuKCaoGZhangXLiuRZouWWuSPretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft modelInt J Nanomedicine2010585386021042547
- SutendraGDromparisPBonnetSPyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertensionJ Mol Med (Berl)201189877178321809123
- ArcherSLFangYHRyanJJPiaoLMetabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertensionPulm Circ20133114415223662191
- PiaoLSidhuVKFangYHFOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetateJ Mol Med (Berl)201391333334623247844
- KimJBYuYMKimSWLeeJKAnti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brainBrain Res200510601–218819216226231
- TsaiBMLahmTMorrellEDEthyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expressionJ Surg Res2008145113013417574585
- GrobeACWellsSMBenavidezEIncreased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthaseAm J Physiol Lung Cell Mol Physiol20062906L1069L107716684951
- SteinhornRHAlbertGSwartzDDRussellJALevineCRDavisJMRecombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertensionAm J Respir Crit Care Med2001164583483911549542
- McMurtryMSBonnetSWuXDichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosisCirc Res200495883084015375007
- RosenfeldtFLHaasSJKrumHCoenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trialsJ Hum Hypertens200721429730617287847
- van ZoelenMAYangHFlorquinSRole of Toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivoShock200931328028419218854
- van BeijnumJRBuurmanWAGriffioenAWConvergence and amplification of Toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)Angiogenesis2008111919918264787
- TreutigerCJMullinsGEJohanssonASHigh mobility group 1 B-box mediates activation of human endotheliumJ Intern Med2003254437538512974876
- FiuzaCBustinMTalwarSInflammation-promoting activity of HMGB1 on human microvascular endothelial cellsBlood200310112652266012456506
- KimuraSEgashiraKChenLNanoparticle-mediated delivery of nuclear factor κB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertensionHypertension200953587788319307469
- ChenLNakanoKKimuraSNanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertensionHypertension201157234335021220711